{"id":"95399a24-a83e-4f84-af36-1988c4d4ba2b","arxiv_id":"2607.08953","paper_version":1,"verdict":"CONDITIONAL","confidence":"HIGH","novelty_score":5.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":3,"one_line_summary":"FairSelect systematically evaluates single and multi-level fairness interventions with intersectional metrics, finding non-additive, context-dependent effects on synthetic bias tests and a real AF stroke-risk task.","lead":"FairSelect is a modular toolkit that tests fairness fixes for ML models alone and in multi-stage combinations, including for overlapping demographic groups. It matters because clinical prediction models can systematically under-serve some patient subgroups, and practitioners currently lack systematic guidance on which fixes actually help.","discovery_kind":"new_method","skeptic_critique":{"model":"grok-4.5","headline":"The clinical claim that multi-level search reliably surfaces useful configurations rests on one AF stroke cohort without uncertainty quantification or released code.","rationale":"The Reader correctly isolates the weakest assumption: synthetic datasets engineered to match each technique’s intended bias mechanism plus one real-world AF stroke cohort are insufficient to underwrite both toolkit correctness and the general claim that multi-level search reliably surfaces useful clinical configurations. My stress test focuses on the same soft spot but sharpens it to the missing uncertainty quantification and single-cohort nature of the only results that speak to real clinical utility (Section 6). The synthetic half is internally consistent and does not need further attack; the non-additive interaction claim is well-supported by the wide EO_diff ranges and the many counterproductive combinations. Because the paper already flags the single-task limitation in §7 and presents transparent negative findings, the appropriate verdict remains CONDITIONAL rather than REJECT or ACCEPT. No stronger internal inconsistency or hidden assumption was found that would move the needle further.","tokens_in":14580,"tokens_out":592,"duration_ms":8129,"concrete_test":"Re-run the top 5 multi-level configurations from Table 5 on 200 bootstrap resamples of the test set (or an independent All of Us temporal hold-out) and report 95% CIs for ΔEO_diff, ΔDP_diff, and ΔAUROC; if the intervals for the claimed dual improvements routinely include zero or reverse sign, the clinical utility claim weakens.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The paper's strongest claim is that fairness interventions interact non-additively and that FairSelect systematically identifies strategies improving subgroup equity while preserving performance in clinical ML. Synthetic stress tests (Methods 3.3) cleanly show that techniques reduce the disparities they were engineered to target, and multi-level averages improve EO_diff/DP_diff more than single methods. The clinical half (Section 6, Tables 3–5) is the load-bearing support for the practical claim: only ~22–26% of single- or multi-level runs improve fairness, many worsen it, and a handful of combinations (e.g., RF reweight\to ensemble, DT reweight\to ensemble\to reject-option) improve both fairness and AUROC/ACC. Those selected “best” rows are presented as point estimates with no standard errors, bootstrap intervals, or multiplicity correction, and the development/test split is a single geographic-temporal partition of one All of Us AF stroke cohort (N_test=2383, stroke rate 14.8%). Without uncertainty or independent cohorts, it is impossible to know whether the reported non-additive successes are stable or sampling artifacts, so the leap from “variable on this task” to “practical framework for clinical ML” remains under-supported.","agreement_with_reader":"agree"},"referee_report":{"model":"grok-4.5","summary":"This paper introduces FairSelect, a modular Python toolkit for systematically evaluating fairness mitigation methods applied singly and in combination across pre-, in-, and post-processing stages of supervised ML pipelines, with support for multiple model architectures and intersectional subgroup metrics. The authors validate the toolkit on synthetic clinical datasets engineered to isolate specific bias mechanisms and on a real-world replication of two-year stroke risk prediction in atrial fibrillation using All of Us EHR data. Synthetic results show that targeted methods reduce the intended disparities and that multi-level combinations yield larger average fairness gains with modest utility cost. On the clinical task, effects are highly variable: only a minority of single-method (~22–27%) and multi-level (~26%) runs improve DP_diff/EO_diff, many worsen them, while a small set of combinations improve both fairness and AUROC/accuracy. The central claim is that fairness interventions interact non-additively and context-dependently, so systematic multi-level search is needed to identify useful configurations in clinical ML.","tokens_in":14876,"tokens_out":1383,"duration_ms":23357,"significance":"The work addresses a genuine practical gap: fairness methods are usually evaluated in isolation and along single demographic axes, leaving little guidance for multi-stage, intersectional settings common in healthcare. The honest clinical finding that most interventions are ineffective or counterproductive is itself a useful contribution and aligns with STANDING Together-style calls for subgroup-aware evaluation. Strengths include a clear multi-stage experimental design, a controlled synthetic stress-test suite that maps bias mechanisms to techniques, support for seven model classes, and explicit reporting of both successes and failures rather than only cherry-picked wins. If the toolkit is released and the clinical evidence is statistically strengthened, FairSelect could become a useful benchmarking and selection framework for clinical ML developers. The non-additivity result is empirically grounded and of interest beyond the specific AF stroke task.","major_comments":[{"comment":"Section 6 / Tables 4–5: The load-bearing clinical claim that multi-level search can surface configurations that improve both fairness and utility rests on selected “best” point estimates (e.g., RF reweight→ensemble; DT reweight→ensemble→reject-option) with no standard errors, bootstrap intervals, cross-validation folds, or multiplicity correction. Given that only ~22–26% of runs improve EO_diff/DP_diff and many worsen them, it is unclear whether the reported successes are stable or sampling artifacts on a single geographic-temporal test split (N_test=2,383). Uncertainty quantification (or at least repeated splits / bootstrap) is needed for these headline configurations.","section":null},{"comment":"Sections 4–6 and Limitations §7: External validity for the claim that FairSelect is a “practical framework … in clinical machine learning” is thin. Validation uses one AF stroke-risk cohort (All of Us) plus synthetic data designed to match the techniques’ intended mechanisms. The Limitations section acknowledges single-task scope, but the Abstract/Conclusion still generalize to clinical ML. Either narrow the claim to this task class or add at least one additional clinical prediction task (or independent cohort) so that non-additivity and “useful combination” findings are not single-dataset phenomena.","section":null},{"comment":"Methods 3.1 and Results §§5–6: Intersectional evaluation is a stated contribution, yet clinical tables report only aggregate DP_diff and EO_diff (race and gender). It is not clear how intersectional subgroup disparities are computed, aggregated, or filtered for low-n cells (the toolkit’s filtering is mentioned only briefly in §7). Without subgroup-level or intersection-specific reporting for the clinical task, the claim that FairSelect systematically improves intersectional equity is under-supported relative to the single-axis metrics shown.","section":null},{"comment":"Methods / Availability: Reproducibility of the toolkit and clinical pipeline is not established in the manuscript. There is no statement of code/data release for FairSelect, the synthetic generator, or the All of Us extraction scripts (beyond citing the prior AF study). For a software-and-evaluation contribution whose value is “systematic search,” public release (or a clear availability plan) is load-bearing for the practical claim.","section":null}],"minor_comments":[{"comment":"Throughout: residual line-break artifacts and spacing errors appear in the text (e.g., “approac hes”, “sou rces”, “techni ques”, “t oolkit”, “de mographic”). Clean typesetting before resubmission.","section":null},{"comment":"Table 1: The prose states four post-processing techniques, but the visible table body lists three (Multiaccuracy Boosting, Group-Specific Youden, Reject-Option). Align the count and complete the missing row (or correct the count).","section":null},{"comment":"Section 3.3: Synthetic generation is described at a high level; a short appendix table mapping each synthetic scenario to the intended technique and the primary fairness metric expected to move would make the stress-test design easier to audit.","section":null},{"comment":"Table 4: Logistic Regression + Local Massaging reports AUROC (Δ) as 0.748 (0.238), which is inconsistent with the baseline AUROC of 0.773 in Table 3 (a large positive Δ would imply a large increase, not a decrease). Check sign/value of deltas for consistency.","section":null},{"comment":"Related Work: FairLogue is cited as arXiv 2604.04858 (same group). Briefly clarify how FairSelect differs from FairLogue so readers can place the contribution relative to the authors’ prior toolkit.","section":null},{"comment":"Section 6.3: “no combined method consistently improve both DP_diff and EO_diff” — grammar (“improve” → “improved”).","section":null}],"recommendation":"major_revision","confidential_remarks":"The paper is a solid empirical/software contribution with unusually honest negative results on the clinical task; I would not reject it. The main risk is overclaiming general clinical utility from one AF cohort and selected point estimates. If the authors add uncertainty quantification, clarify intersectional reporting, and release code (or a clear availability statement), this is close to a useful methods/tools paper for a fairness or clinical ML venue. Scope fit depends on whether the journal prioritizes toolkits and empirical multi-method studies versus purely theoretical fairness work."},"author_rebuttal":null,"desk_editor":{"model":"grok-4.5","letter":"The useful takeaway is that FairSelect packages twelve existing pre/in/post techniques into a single-vs-combined loop with intersectional reporting, and the clinical half shows most runs (only ~22–26 %) fail to improve EO/DP while a few combinations improve both fairness and AUROC. That non-additive, often counterproductive pattern is the actual new empirical result; the toolkit itself is the engineering artifact.\n\nWhat they do well: synthetic stress tests are cleanly designed so each dataset isolates a bias mechanism that matches a technique’s intended correction, and the directional effects land as expected. The clinical replication of the AF stroke task is transparent about baseline disparities and about how many interventions backfire. Tables 3–5 report both the failures and the selected best rows (RF reweight\to ensemble, DT combinations, etc.) without overselling. Citations cover the multi-level and intersectional literature they build on; self-citation of FairLogue is minor and not load-bearing. No circular math—just measured outcomes.\n\nSoft spots, in proportion: the leap from “variable on this All of Us AF cohort” to “practical framework for clinical ML” is under-supported. One geographic-temporal split (N_test=2383), point estimates only, no SEs/bootstraps/multiplicity correction, and no released code or synthetic generators. Hyperparameters (K, thresholds, model settings) are free and unreported in detail. These are real limits on generalizability, not fatal design flaws; the paper already flags the single-task and combinatorial-cost issues in §7.\n\nThis is for people who actually ship clinical models and need a systematic way to search the multi-stage fairness space rather than for theorists of fairness definitions. The honest negative findings and the combinatorial framing make it worth a serious referee’s time even if the clinical claim needs tightening. I would engage: cite the non-additivity evidence and the toolkit idea, and push for uncertainty and release. Send it to review.","headline":"Solid engineering toolkit with honest negative clinical results; the multi-level non-additivity claim is real but rests on one cohort without uncertainty or code.","tokens_in":15445,"tokens_out":486,"would_cite":true,"duration_ms":5933,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"grok-4.5","headline":"Fairness fixes interact non-additively: combining them across the ML pipeline often works better than any single method, but only if you systematically test the combinations.","keywords":["algorithmic fairness","bias mitigation","intersectionality","multi-level fairness","clinical machine learning","fairness-utility tradeoff","stroke risk prediction"],"falsifier":"Apply FairSelect to several additional, independent clinical prediction tasks with different outcome prevalences and demographic mixes; if multi-level combinations never outperform the best single method on both fairness and utility, or if the synthetic-to-real transfer fails, the general claim collapses.","tokens_in":15472,"feed_emoji":"⚖️","tokens_out":617,"duration_ms":11743,"temperature":0.7,"pith_summary":"Most fairness methods are tested alone and on one demographic slice at a time. That leaves practitioners without guidance when real disparities cut across intersecting groups and across data preparation, model training, and decision thresholds. FairSelect is a toolkit that runs single methods and multi-stage combinations on the same models, reports fairness and accuracy for both single and intersectional subgroups, and surfaces the fairness–utility trade-offs. On synthetic clinical data built to isolate known bias mechanisms, the intended methods usually reduced the targeted gaps and multi-level combinations produced larger average fairness gains with only modest accuracy loss. On a real two-year stroke-risk prediction task, effects were highly variable: some combinations improved both fairness and performance, while many others did nothing or made disparities worse. The paper’s claim is that fairness interventions do not add up cleanly; useful configurations must be found by systematic search rather than assumed.","feed_headline":"Fairness fixes don’t add up: you have to search the combinations","feed_subtitle":"A toolkit shows multi-stage fairness mixes can help or hurt clinical models—only testing tells which","key_machinery":"FairSelect: a modular pipeline that applies any chosen set of pre-, in-, and post-processing fairness techniques both singly and in combination, then scores the resulting models on standard performance metrics and on demographic-parity and equalized-odds differences computed over both single attributes and their intersections.","core_discovery":"Fairness interventions interact in non-additive, context-dependent ways. Targeted single methods generally reduce the disparities they were designed for under controlled conditions, yet multi-level combinations produce larger average fairness gains (and sometimes joint fairness-and-performance improvements) only when the specific mix of techniques, model, and data is evaluated systematically; many combinations remain ineffective or counterproductive.","pith_inferences":[],"forward_implications":[],"fun_headline_variants":["Fairness fixes interact non-additively: combinations must be searched","Multi-stage fairness mixes help or hurt only when tested together","Single fairness methods work; multi-level gains need systematic checks","FairSelect: non-additive fairness effects demand full pipeline evaluation","Targeted bias cuts work alone; combos improve equity only if chosen well"],"cache_read_input_tokens":128,"weakest_assumption_plain":"The claim rests on synthetic datasets each engineered to isolate one bias mechanism plus a single real-world atrial-fibrillation stroke-risk cohort being enough to show that multi-level search reliably finds useful clinical fairness configurations.","fun_headline_variants_meta":{"raw":{"variants":["Fairness fixes interact non-additively: combinations must be searched","Multi-stage fairness mixes help or hurt only when tested together","Single fairness methods work; multi-level gains need systematic checks","FairSelect: non-additive fairness effects demand full pipeline evaluation","Targeted bias cuts work alone; combos improve equity only if chosen well"]},"model":"grok-4.5","effort":"low","cost_usd":0.005302,"raw_usage":{"total_tokens":1461,"prompt_tokens":770,"num_sources_used":0,"completion_tokens":77,"cost_in_usd_ticks":53020000,"prompt_tokens_details":{"text_tokens":770,"audio_tokens":0,"image_tokens":0,"cached_tokens":256},"completion_tokens_details":{"audio_tokens":0,"reasoning_tokens":614,"accepted_prediction_tokens":0,"rejected_prediction_tokens":0}},"tokens_in":770,"tokens_out":77,"duration_ms":6520,"temperature":1.0,"reasoning_tokens":614,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-07-13T05:32:03.002660+00:00","model_set":{"reader":"grok-4.5"},"falsifier":"Apply FairSelect to several additional, independent clinical prediction tasks with different outcome prevalences and demographic mixes; if multi-level combinations never outperform the best single method on both fairness and utility, or if the synthetic-to-real transfer fails, the general claim collapses.","supporting_citations":[],"review_version":1}